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Abstract
Placebo and nocebo effects are known to play a key role in treatment effects in a wide variety of conditions. These effects
have frequently been investigated with regard to pain and also in other physical sensations, but have hardly been
investigated with regard to itch. In addition, neither in pain nor in any other physical sensation, the single and combined
contribution of the expectancy mechanisms of conditioning and verbal suggestion have ever been investigated in both
placebo and nocebo effects within one design. For the first time, the role of verbal suggestion and conditioning in placebo
and nocebo effects on itch was experimentally investigated. Expectations about itch stimuli were induced in healthy
subjects by verbal suggestion, conditioning, or a combination of both procedures, and compared with a control group
without expectation induction. Itch was induced electrically by means of quantitative sensory testing. Significant placebo
and nocebo effects were induced in the group in which combined procedures of conditioning and verbal suggestion were
applied in comparison with the control group. The conditioning and verbal suggestion procedures applied individually did
not induce significant placebo and nocebo effects when compared with the control group. The results of this study extend
existing evidence on different physical sensations, like pain, by showing that also for itch, the combination of conditioning
and verbal suggestion is most promising in inducing both placebo and nocebo effects. More research on placebo and
nocebo effects at a perceptive and neurobiological level is warranted to further elucidate the common and specific
mechanisms underlying placebo and nocebo effects on itch and other physical sensations.
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Introduction
Placebo and nocebo effects are treatment effects, unrelated to
the treatment mechanism, which are induced by patients’
expectations of improvement or worsening respectively [1–3].
Placebo and nocebo effects are known to contribute to the
outcome of treatment effects for a range of symptoms and
conditions like Parkinson’s disease, gastrointestinal disorders,
nausea, fatigue and pain [1,3–8]. In contrast to the extensive
placebo research mainly on pain, hardly any placebo research has
focused on itch, which is a common symptom of several conditions
and diseases, such as dermatological and systemic diseases, and
can be a considerable burden to patients especially when
symptoms are chronic [9,10]. Moreover, itch particularly seems
highly susceptible to suggestion, as demonstrated by the phenom-
enon of ‘‘contagious’’ itch: e.g., watching someone scratch himself
can induce a sensation of itch in the perceiver (e.g., [11,12]).
Therefore, placebo and nocebo effects might be relevant to itch in
particular.
Mechanisms underlying placebo and nocebo effects have
extensively been investigated, especially in the field of pain.
Expectation induction mechanisms of verbal suggestion and
conditioning have been identified as central processes eliciting
placebo and nocebo effects, by decreasing or increasing symptoms
respectively, when administering an inert (placebo) treatment or
agent [2,13,14]. With regard to pain, verbal suggestion has been
shown to induce short-term nocebo effects, whereas conditioning is
particularly relevant to induce placebo effects and more robust
nocebo effects [13,15,16]. Also in other physical sensations such as
fatigue and nausea conditioning seems to be particularly relevant
[5,8,17]. With regard to itch, the role of conditioning in placebo or
nocebo effects has not been investigated yet, although, there is
some evidence for the role of verbal suggestion in placebo and
nocebo effects on itch. For example, patients with atopic dermatitis
react more strongly to histamine after nocebo-related itch
suggestions [18], and in a previous experiment, we showed that
verbal suggestion alone can induce nocebo and possibly also
placebo effects on itch [19].
Most studies investigating the role of conditioning in placebo
and nocebo effects applied conditioning in combination with
verbal suggestion. The few studies that used a conditioning
procedure without verbal suggestion yielded mixed results [20–
23]. Hardly any research has compared the single and combined
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contributions of verbal suggestion and conditioning to placebo
effects. Moreover, to the best of our knowledge, no direct
comparison of verbal suggestion, conditioning, and the combina-
tion of both has been made yet with regard to nocebo effects
within one design.
The aim of this study was to investigate the role of verbal
suggestion and conditioning in both placebo and nocebo effects on
itch. Alike pain and other physical sensations, it was hypothesized
that the expectation induction, particularly the combination of
conditioning and verbal suggestion, would result in decreased
(placebo) and increased (nocebo) itch in comparison to a control
procedure. In addition, it was explored whether individual
characteristics related to negative (e.g., neuroticism) or positive
(e.g., optimism) outcome expectancies were associated with
individual placebo and nocebo responses [13,24–27].
Methods
Ethics statement
The study was approved by the regional medical ethics
committee CMO regio Arnhem-Nijmegen and follows the rules
stated in the Declaration of Helsinki. All participants gave written
informed consent and were reimbursed for their participation.
Participants and general procedure
Healthy subjects were recruited at the campus of the Radboud
University Nijmegen, Nijmegen, the Netherlands. Exclusion
criteria were severe morbidity (e.g., skin disease, multiple sclerosis,
diabetes mellitus), psychiatric disorders (e.g., depression), color
blindness, regular use of medication in the last 3 months, use of
pacemaker, and current or past chronic itch or pain. Participants
were told that the purpose of the study was to determine sensitivity
to itch stimuli. At least one week prior to the experiment, a session
took place in which previous experiences and expectations of
sensations such as itch and pain of all subjects were assessed
(results not reported here). In addition, subjects were sent self-
report questionnaires about individual characteristics to be
completed at home. As one subject unexpectedly went abroad
after the first session, 95 subjects completed the experiment. All 95
subjects were of Dutch nationality, and were aged 18 years or
older (mean age 22.763.2 years); 77% were women. Of the
subjects, 54% had a partner (13% married or living with a partner)
and 58% used hormonal contraceptives. On the test day, the mean
baseline levels of itch and pain were 0.5 (SD=0.8) and 0.5
(SD=0.7), respectively, as rated on a visual analogue scale (VAS)
ranging from 0 (no itch/pain at all) to 10 (worst itch/pain ever
experienced).
Test day procedure
For the test day, all subjects were asked to refrain from drinking
coffee, tea, or energy drink from one hour before testing, which
took place at a fixed time in the afternoon. A schematic overview
of the study is displayed in Figure 1. At first, all subjects held their
hands in a warm water bath at about 32uC for 3 minutes [28], in
order to attain a comparable baseline wrist skin temperature
among participants. Then the itch thresholds were determined by
gradually increasing the intensity of the electric current with a
ramping procedure (see Methods; Itch induction). Thereafter, subjects
were randomly assigned to one of four groups, using a computer
generated randomization list. Since the instructions given to the
subjects differed in accordance with the group the subjects were
allocated to, only subjects were blinded for the randomization to
different groups. In line with previous conditioning studies of
nocebo and placebo effects on pain [15,16], the experimental
session comprised two phases: a learning phase and a testing
phase. In both phases, itch stimuli were preceded by visual cues
(colored lights, i.e., green, yellow, and red lights) displayed on a
computer screen. The learning phase consisted of two blocks, in
which either no expectations were induced or participants received
verbal suggestion, conditioning, or a combination of both
procedures, to induce expectations about the intensity of the itch
stimuli. In this phase, itch stimuli of a varying intensity were
applied, preceded by a cue (6x green, 6x yellow, and 6x red cue).
In the testing phase, itch stimuli were all applied at medium
intensity, preceded by a cue (5x green, 5x yellow, and 5x red cue).
After the threshold measurements and in-between the different
experimental blocks, there was a standardized 10-minute break in
which participants were provided with a selected number of
magazines to read with a neutral content (about nature and home
decoration), and they were offered a small snack and herbal tea or
water (see also Fig. 1)
Experimental groups and control group
The experimental design is displayed in Figure 2. In the verbal
suggestion group, expectations of low, neutral, and high levels of itch
were raised in subjects by telling them that different cues (colored
lights on the computer screen) indicated that the stimulus intensity
would be altered. This change would be brought about by a third
electrode, which was actually a placebo or sham electrode (inactive
electrode): ‘‘A green light will signal the activation of the third
electrode that induces a decrease in the intensity of the itch
stimulus. A red light will signal an increase in the intensity of the
itch stimulus by the activation of the electrode, and the yellow light
will indicate that the third electrode is turned off and will not
change the intensity of the itch stimulus’’. Regardless of the color
of the cue displayed, all stimuli had a medium intensity. In the
conditioning group, expectations of low, neutral, and high levels of
itch were raised in subjects by the repeated pairing of the green,
yellow, and red cues with low, medium, and high itch stimulus
intensities, respectively. The current intensities (mA) for the low,
medium, and high stimulus intensities were determined according
to the participants’ individual itch thresholds (see Methods; itch
induction). No verbal suggestion was given to avoid any verbal
suggestion effects, i.e., subjects were not given information about
the stimulus intensity, but were merely told that several itch stimuli
would be applied after the presentation of color cues. In the
conditioning with verbal suggestion group, the conditioning procedure
and the verbal suggestion procedure were combined, thus applying
stimuli of low, medium, and high intensity concurrently with the
green, yellow, and red cues, respectively, and the corresponding
verbal suggestion. In the control group, no expectations regarding the
itch stimuli were induced, neither by verbal suggestion nor by
conditioning, i.e., subjects were not given information about the
colored cues or stimulus intensity, and itch stimuli were given
independently of the colored cue at a predetermined random
order at low, medium, and high intensity. Unlike in the learning
phase, in the testing phase only stimuli of medium intensity were
applied in all groups. The verbal suggestion given in the testing
phase corresponded with the verbal suggestion given in the
learning phase (See Fig. 2. for the experimental design).
Itch induction
Itch was induced by means of electrical stimulation by a
constant current stimulator (Isolated Bipolar Constant Current
Stimulator DS5, Digitimer, United Kingdom), and delivered to
the inner side of the non-dominant wrist through two surface
electrodes (a disk electrode of ø 1 cm and a reference electrode of
ø 2 cm, VCM Medical, the Netherlands). The stimulator was
Placebo and Nocebo Effects on Itch
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coupled to a data acquisition system (NI-DAQmx, National
Instruments, Hungary), which was controlled by a laptop. One
electrode was applied 1.5 cm proximal to the triquetrum, at the
center of the inner wrist, while the reference electrode was applied
2 cm below. A third (sham) electrode was placed about 1 cm left
from the two real electrodes and attached to the back of the
stimulator. Stimuli were applied at 50-Hz frequency with a pulse
duration of 100 ms [29] and at a continuously increasing current
intensity (0.05 mA/s) up to a maximum current intensity of 5 mA.
After each stimulus, participants were asked to report the level of
itch on a visual analogue scale (VAS) ranging from 0 (no itch at all)
to 10 (worst itch ever experienced). The following thresholds were
measured three times by gradually increasing the current intensity
from 0 mA up to the intensity at which the respective threshold
had been reached: ‘‘the first moment you feel some itch’’ (IT1);
‘‘the first moment you feel the urge to scratch’’ (IT2); and ‘‘the first
moment you cannot resist the urge to scratch’’ (IT3). The mean of
these thresholds was used for the calculation of the individual
current intensities of the low, medium, and high itch stimulus
applied in the experimental phase. In-between every stimulus
applied in the learning and testing phase, there was a 2-minute
interval, in which filler tasks (e.g., puzzles) were given to diminish
possible influence of itch evoked by previously applied stimuli on
subsequent stimuli. The interval could be extended to a maximum
of 4 minutes if the level of itch after 2 minutes was $2 on a VAS.
Figure 1. Flow diagram showing the experimental procedures of the study in chronological order.
doi:10.1371/journal.pone.0091727.g001
Figure 2. Experimental design. Subjects were randomly assigned to one of four groups: verbal suggestion; conditioning; verbal suggestion with
conditioning; and control. In the learning phase verbal suggestion and conditioning procedures depended on the experimental group. In the testing
phase the verbal suggestion was in correspondence with the verbal suggestion applied in the learning phase, while all participants received itch
stimuli of a medium intensity.
doi:10.1371/journal.pone.0091727.g002
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Questionnaires
Individual psychological characteristics of optimism, hope,
neuroticism, extraversion, negative affect and worrying were
assessed by means of self-report questionnaires, previously shown
to have satisfactory reliability and validity.
Optimism
The Revised Life Orientation Test (LOT-R) [30] was used to
measure optimism, the tendency to expect positive outcomes. The
LOT-R consists of 10 items scored on a 5-point Likert scale
ranging from 0 (‘‘Strongly Disagree’’) to 4 (‘‘Strongly Agree’’).
Total scores range from 0 to 24, with higher scores indicating
higher levels of dispositional optimism. In the present study,
Cronbach’s alpha was 0.79.
Hope
The Dispositional Hope Scale (DHS) was used to measure hope,
the tendency to experience a reciprocally derived sense of
successful agency and pathways [31,32]. The DHS consist of 12
items scored on a 8-point Likert scale ranging from 1 (‘‘Definitely
False’’) to 8 (‘‘Definitely true’’), with higher scores indicating
higher levels of hope. In the present study, Cronbach’s alpha was
0.78.
Neuroticism & Extraversion
The Eysenck Personality Questionnaire (EPQ) was used to
measure neuroticism, the tendency to experience more negative
affect and negative outcome expectations, and extraversion, the
tendency of having more outgoing, talkative, and energetic
behavior [33]. The neuroticism and extraversion subscales consist
of 22 and 19 ‘‘yes/no’’ items, respectively. Higher scores indicate
higher levels of neuroticism and extraversion. In the present study,
Cronbach’s alpha was 0.84 for neuroticism and 0.86 for
extraversion.
Negative affect
The Hospital Anxiety and Depression Scale (HADS) was used
to measure negative affect characterized by symptoms of
depression and anxiety [34]. The HADS consists of 14 items
scored on a 4-point Likert scale ranging from 0 (‘‘no problem’’) to
3 (‘‘severe problem’’), with higher scores indicating higher levels of
negative affect. In the present study, Cronbach’s alpha was 0.80.
Worrying
The Penn State Worry Questionnaire (PSWQ) [35] was used to
measure worrying, which includes the tendency to experience
more negative outcome expectancies. The PSWQ consists of 16
items scored on a 5-point Likert scale, ranging from 1 (‘‘not at all
typical of me’’) to 5 (‘‘very typical of me’’), with higher scores
indicating greater worrying. In the present study, Cronbach’s
alpha was 0.93.
Statistical analysis
All analyses were performed using SPSS 20.0 for Windows
(SPSS Inc. Chicago, Illinois, USA). Analyses of variance
(ANOVA) and Chi-square tests were used to test for baseline
differences in demographic variables between the four groups.
Means of the VAS itch scores were calculated for the learning and
testing phases in all groups. Variables were checked for outliers
and skewness as these can severely limit the usefulness of the mean
as measure for location. Since there was no indication of problems
in this respect, untransformed variables were analyzed. In order to
be able to measure nocebo and placebo effects, i.e., by an increase
or a decrease in itch respectively, an intermediate itch intensity
was introduced by applying a stimulus at medium intensity
preceded by a yellow cue along with a neutral expectation. The
nocebo effect was then defined as the difference between the mean
itch VAS scores associated with the five red cues and the five
yellow cues in the testing phase, and the placebo effect was defined
as the difference between the mean itch VAS scores associated
with the five green cues and the five yellow cues in the testing
phase. Univariate analyses of variance (ANOVAs) were performed
with group as between-subject factor for nocebo and placebo effects,
in order to test the hypothesis, i.e., that the experimental groups
would display significant nocebo and placebo effects in compar-
ison with the control group. Post hoc Dunnett tests were conducted to
compare the experimental groups separately with the control group.
The effectiveness of the expectation induction procedures was also
exploratively assessed during the learning phase. Again, separate
ANOVAs and post hoc Dunnett tests were performed as described
above, exploring the difference in itch VAS scores between the
green- or red- and yellow-associated stimuli in the learning phase.
Exploratively, in the three experimental groups Pearson correla-
tion coefficients were calculated between the nocebo and placebo
effects and questionnaire scores for individual characteristics. For
all analyses, the level of statistical significance was set at p,0.05.
Results
Experimental and control groups
Randomization of the subjects across the different experimental
and control groups resulted in a total of 23 subjects in the verbal
suggestion group, 24 subjects in the conditioning group, 23 subjects in the
conditioning with verbal suggestion group, and 25 subjects in the control
group. There were no significant between-group differences with
regard to age, gender, use of hormonal contraceptives, and
baseline levels of itch and pain on the test day.
Nocebo effects
Learning phase for induction of nocebo effects. Table 1
displays the mean (6SD) itch VAS scores evoked by the stimuli
associated with the red and yellow cues during the learning phase
for the four groups. When exploring whether the difference in the
levels of electrically evoked itch (i.e., red minus yellow cue) would
be larger in the three experimental groups than in the control group,
Univariate analysis of variance (ANOVA) revealed a significant
between group effect (F(3,91) = 49.528, p,0.001). Post hoc
Dunnett tests indicated a significantly larger itch VAS difference
score between the red- and yellow-associated stimuli, for the verbal
suggestion group (p,0.001), the conditioning group (p,0.001) and the
conditioning with verbal suggestion group (p,0.001) as compared with
the control group.
Testing phase nocebo effects. Table 2 displays the mean
(6SD) itch VAS scores evoked by the stimuli associated with the
red and yellow cues during the testing phase for each group (in
which all stimuli were applied at medium intensity), and the mean
nocebo effect for each group is shown in Figure 3. Univariate
ANOVA showed a significant difference in the magnitude of the
nocebo effect in the different groups (F(3,91) = 2.995, p=0.035).
Post hoc Dunnett tests comparing the experimental groups with
the control group indicated a significant nocebo effect in the
conditioning with verbal suggestion group (p=0.020), a borderline
significant nocebo effect in the verbal suggestion group (p=0.063),
and no significant nocebo effect in the conditioning group when
compared with the control group (See Fig. 3.).
Placebo and Nocebo Effects on Itch
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Placebo effects
Learning phase for induction of placebo effects. Table 1
displays the means and standard deviations (SD) of the itch VAS
scores evoked by the stimuli associated with the green and yellow
cues during the learning phase for the four groups. When
exploring whether the difference in the levels of electrically evoked
itch (i.e., yellow minus green cue) would be larger in the three
experimental groups than in the control group, Univariate analysis of
variance (ANOVA) revealed a significant group effect
(F(3,91) = 16.742, p,0.001). Post hoc Dunnett tests indicated a
significantly larger itch VAS difference score between the green-
and yellow-associated stimuli, for the conditioning group (p=0.002)
and the conditioning with verbal suggestion group (p,0.001), as
compared with the control group. In the comparison to the control
group, the verbal suggestion group did not differ in itch VAS difference
score between the green- and yellow-associated stimuli.
Testing phase placebo effects. Table 2 displays the mean
(6SD) itch VAS scores evoked by the stimuli associated with the
green and yellow cues during the testing phase for each group (in
which all stimuli were applied at medium intensity), and the mean
placebo effect for each group is shown in Figure 4. Univariate
ANOVA showed a significant difference in the magnitude of the
placebo effect in the different groups (F (3,91) = 6.154, p=0.001).
Post hoc Dunnett tests comparing the experimental groups with
the control group indicated a significant placebo effect in the
conditioning with verbal suggestion group (p=0.009), but no significant
differences in the placebo effect were found in the verbal suggestion
group or the conditioning group when compared with the control group
(See Fig. 4.).
Individual characteristics
Nocebo effect. In the conditioning with verbal suggestion group,
significant correlation coefficients were found between a greater
nocebo response and more worrying (r=0.485; p=0.019), more
negative affect (r=0.433; p=0.039), less hope (r=20.452;
p=0.030), and lower levels of extraversion (r=20.511;
p=0.013), but not with neuroticism or optimism. No significant
correlations were found in the other experimental groups.
Placebo effect. The magnitude of the placebo effect was not
significantly correlated with the individual characteristics of
optimism, hope, extraversion, neuroticism, negative affect, and
worrying in any of the three experimental groups, except for a
significant correlation coefficient between a greater placebo effect
and less hope in the conditioning with verbal suggestion group
(r=20.507; p=0.014).
Discussion
For the first time, expectation induction procedures of verbal
suggestion, conditioning and the combination of both were
investigated with regard to both nocebo and placebo effects on
itch. Results show that nocebo and placebo effects can be induced
on itch, with the strongest effects elicited by a combination of
conditioning and verbal suggestion rather than by either
procedure alone. These results are in line with research in nocebo
and placebo effects on pain and other physical sensations such as
nausea and fatigue (e.g., [5,8,13,15]).
The subjects receiving both conditioning and verbal suggestion
procedures had significantly higher (nocebo) and lower (placebo)
levels of induced itch than did the subjects receiving the control
procedure. Additional support for these findings was found in the
learning phase, during which there was a similar pattern of
changes in itch VAS scores in response to nocebo and placebo
cues. These findings are consistent with earlier research on pain
which showed that the combination of conditioning and verbal
suggestion evoked robust hyperalgesic and analgesic effects
[13,15,36]. Moreover, when verbal suggestion procedures were
combined with conditioning, generally larger and longer-lasting
nocebo and placebo effects could be induced when compared with
these procedures alone [13,15,20,22,23,36,37]. In addition, also in
other physical symptoms further support has been found for the
combination of conditioning and verbal suggestion such as in
nausea and fatigue [5,38]. For inducing nocebo and placebo
effects on various physical sensations, the combination of these
expectation induction mechanisms seems most promising.
Verbal suggestion (without conditioning) elicited a marginally
significant nocebo effect on itch when compared with a control
procedure during the testing phase, and elicited a robust
significant nocebo effect in the learning phase. Previous research
has shown that robust nocebo effects on itch [19] and pain
[1,2,13,14] can be induced by verbal suggestion. In contrast,
placebo effects were not significantly induced by verbal suggestion
when compared with a control procedure, i.e., subjects did not
experience less itch when told that the stimulus would evoke less
itch, than when given neutral suggestions (control group).
However, indirect indications were found for a placebo effect
within the verbal suggestion group by showing that these subjects
experienced significantly lower levels of itch for the stimuli
associated with the green (placebo) versus the yellow (neutral)
cues (see table 2). Using two phases (learning and testing phase)
might have led to extinction of effects that were present in the first
(learning) phase, while to test for the effects of verbal suggestion a
single phase is sufficient [15].
Table 1.Means and standard deviations for itch VAS scores in
the learning phase for the different groups.
Itch VAS scores (M ± SD)
Group Green cue Yellow cue Red cue
Verbal suggestion 4.5661.81 4.7761.78 5.3961.83
Conditioning 3.7362.07 4.5462.09 5.8462.01
Conditioning & Verbal suggestion 2.3761.75 3.9761.34 6.0461.55
Control 3.5262.00 3.4362.01 2.8761.68
Means (M) and standard deviations (SD) of the visual analogue scale (VAS)
scores for itch in the verbal suggestion group (n= 23), conditioning group
(n = 24), conditioning with verbal suggestion group (n= 23) and control group
(n = 25) in the learning phase.
doi:10.1371/journal.pone.0091727.t001
Table 2.Means and standard deviations for itch VAS scores in
the testing phase for the different groups.
Itch VAS scores (M ± SD)
Group Green cue Yellow cue Red cue
Verbal suggestion 3.2061.91 3.6061.91 3.8762.05
Conditioning 3.3061.87 3.4161.80 3.5961.87
Conditioning & Verbal suggestion 2.4261.68 3.2861.71 3.6562.00
Control 2.3361.62 2.6561.87 2.3861.70
Means (M) and standard deviations (SD) of the visual analogue scale (VAS)
scores for itch in the verbal suggestion group (n= 23), conditioning group
(n = 24), conditioning with verbal suggestion group (n= 23), and control group
(n = 25) in the testing phase.
doi:10.1371/journal.pone.0091727.t002
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Conditioning (without verbal suggestion) did not elicit signifi-
cant nocebo or placebo effects on itch in the testing phase (in
which all itch stimuli were of the same intensity). This finding was
somewhat unexpected since significant altered itch scores were
present in the learning phase. A reason for non-significant effects
of conditioning might be the number or length of learning trials.
The few previous studies that investigated the effects of
conditioning (without verbal suggestion) on pain generally found
significant nocebo or placebo effects for example when more or
longer lasting learning trials were used [20–23]. During condi-
tioning, the perception of an increase or decrease in sensations
after a cue can shape both automatic and conscious expectations
about the given cue [39], and with more or longer conditioning
trials, the learned association may be more predictable. Moreover,
the addition of explicit expectations (by verbal suggestion) might
further amplify the induction of nocebo and placebo effects on
physical sensations, and itch in particular which seems highly
susceptible to suggestion as demonstrated by the phenomenon of
‘‘contagious’’ itch (e.g., [11,12]).
Individual characteristics related to outcome expectancies were,
in contrast to the placebo effect, associated with the nocebo effect
(more negative affect, less extraversion, more neuroticism and less
hope). This is in line with previous findings on nocebo effects
[13,24–27], and studies showing that particularly negative affect
and cognitions can enhance itch [19,40–43]. These findings also
support the idea that negative (aversive responses) rather than
positive (safety responses) expectations may be easier to induce
from an evolutionary perspective in order to promote survival
[15,44], possibly mediated by a tendency to experience more
negative affect and cognitions, such as worrying. These findings
Figure 4. Means and standard error of the mean of the visual analogue scale (VAS) itch scores for the placebo effect (change VAS
score between the green and yellow cues) of the four groups in the testing phase. The asterisks show the level of significance related to
the post hoc Dunnett comparison of the placebo effect between the experimental groups and the control group (**p,0.01; *p,0.05; t= p,0.10).
doi:10.1371/journal.pone.0091727.g004
Figure 3. Means and standard error of the mean of the visual analogue scale (VAS) itch scores for the nocebo effect (change VAS
score between the red and yellow cues) of the four groups in the testing phase. The asterisks show the level of significance related to the
post hoc Dunnett comparison of the nocebo effect between the experimental groups and the control group (**p,0.01; *p,0.05; t= p,0.10).
doi:10.1371/journal.pone.0091727.g003
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also underline the possibly divergent mechanisms underlying
nocebo and placebo effects. While anxiety or stress-related
processes are thought to be involved in nocebo hyperalgesia,
e.g., through an increase in cortisol plasma concentrations, reward
processes are supposed to be involved in placebo analgesia, e.g., by
the activation of dopamine neurotransmission [39,45]. Additional
research into the possible predictors and different mechanisms of
nocebo and placebo responding is clearly required.
Some limitations and implications for future research should be
discussed. First, the number of conditioning trials in the learning
phase might have been insufficient to induce nocebo or placebo
effects in the group receiving conditioning alone (i.e., without
verbal suggestion) [20–22]. Second, placebo effects were not only
found in the experimental groups, as expected, but also in the
control group there was a tendency for a decrease in itch (see
table 2). The expectations of the participants regarding the visual
stimuli may have unintentionally been influenced because, during
the random allocation of cues to a stimulus intensity, the yellow
cue was more often (than by chance) associated with a high
intensity itch stimulus. This could, for example, explain the lack of
a significant placebo effect in the verbal suggestion group in relation to
the control group. Third, in contrast to previous studies investigating
the role of either negative or positive expectations on itch
[18,19,46], in this study we induced nocebo and placebo
expectations at the same time in individual participants. Since
different mechanisms may underlie the induction of nocebo and
placebo effects, this might have tempered the magnitude of the
effects. Fourth, the subjects’ expectations regarding the colored
cues were not assessed explicitly; so that we cannot exclude that
other mechanisms than expectancy effects might be responsible for
the placebo and nocebo effects found in this study. Lastly,
knowledge of nocebo and placebo effects on itch may, in the long
term, help improve therapeutic interventions by reducing unfa-
vorable expectations and enhancing favorable expectations in
patients suffering from chronic itch. It remains to be established
whether the findings of experimentally induced sensations in
healthy subjects can be generalized to patients in a clinical setting.
Moreover, the role of individual characteristics in nocebo and
placebo responsiveness should be elucidated to further personalize
interventions and to optimize treatment outcomes.
In conclusion, this study showed that, in accordance with
research on other physical sensations, the combination of
conditioning and verbal suggestion can induce significant nocebo
and placebo effects on itch. Research on nocebo and placebo
effects at a perceptive and neurobiological level is warranted to
further elucidate the common and specific mechanisms underlying
nocebo and placebo effects on itch and other physical sensations.
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